T12	Subject 147 177	patients with multiple myeloma
T13	Treatment 0 143	Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen
T15	Treat-Disorder 161 177	multiple myeloma
T16	Drug 27 37	bortezomib
T17	Drug 38 50	lenalidomide
T18	Drug 52 65	dexamethasone
T19	Drug 73 83	bortezomib
T20	Drug 84 97	dexamethasone
T11	Potential_therapeutic_event 144 146	in
T21	Combination 37 38	/
T22	Combination 83 84	/
E1	Potential_therapeutic_event:T11 
E2	Combination:T21 arg:T16 arg2:T17 arg3:T18
E3	Combination:T22 arg:T19 arg2:T20